Truvestments Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $283K | Sell |
2,549
-64
| -2% | -$7.1K | 0.06% | 221 |
|
2025
Q1 | $293K | Buy |
2,613
+1,010
| +63% | +$113K | 0.06% | 207 |
|
2024
Q4 | $148K | Buy |
1,603
+104
| +7% | +$9.61K | 0.04% | 247 |
|
2024
Q3 | $126K | Buy |
+1,499
| New | +$126K | 0.03% | 258 |
|
2024
Q2 | – | Sell |
-1,476
| Closed | -$108K | – | 408 |
|
2024
Q1 | $108K | Buy |
1,476
+85
| +6% | +$6.23K | 0.04% | 291 |
|
2023
Q4 | $113K | Buy |
1,391
+775
| +126% | +$62.8K | 0.05% | 248 |
|
2023
Q3 | $46.2K | Sell |
616
-14
| -2% | -$1.05K | 0.02% | 296 |
|
2023
Q2 | $48.5K | Buy |
630
+175
| +38% | +$13.5K | 0.02% | 296 |
|
2023
Q1 | $37.8K | Sell |
455
-237
| -34% | -$19.7K | 0.02% | 318 |
|
2022
Q4 | $59.4K | Buy |
692
+37
| +6% | +$3.18K | 0.03% | 287 |
|
2022
Q3 | $40K | Sell |
655
-199
| -23% | -$12.2K | 0.03% | 271 |
|
2022
Q2 | $53K | Buy |
+854
| New | +$53K | 0.03% | 251 |
|
2022
Q1 | – | Sell |
-849
| Closed | -$62K | – | 317 |
|
2021
Q4 | $62K | Buy |
849
+457
| +117% | +$33.4K | 0.03% | 244 |
|
2021
Q3 | $27K | Buy |
392
+2
| +0.5% | +$138 | 0.01% | 298 |
|
2021
Q2 | $27K | Sell |
390
-1,894
| -83% | -$131K | 0.01% | 300 |
|
2021
Q1 | $148K | Buy |
2,284
+2
| +0.1% | +$130 | 0.08% | 181 |
|
2020
Q4 | $132K | Buy |
2,282
+564
| +33% | +$32.6K | 0.09% | 176 |
|
2020
Q3 | $109K | Buy |
1,718
+33
| +2% | +$2.09K | 0.1% | 145 |
|
2020
Q2 | $129K | Sell |
1,685
-346
| -17% | -$26.5K | 0.13% | 124 |
|
2020
Q1 | $151K | Buy |
+2,031
| New | +$151K | 0.19% | 102 |
|
2019
Q4 | – | Sell |
-1,627
| Closed | -$103K | – | 312 |
|
2019
Q3 | $103K | Buy |
1,627
+2
| +0.1% | +$127 | 0.07% | 175 |
|
2019
Q2 | $110K | Sell |
1,625
-128
| -7% | -$8.67K | 0.07% | 174 |
|
2019
Q1 | $114K | Buy |
+1,753
| New | +$114K | 0.09% | 147 |
|
2018
Q3 | $210K | Buy |
+2,726
| New | +$210K | 0.1% | 173 |
|